Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac Disease

August 13, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search